Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD

Advanced glycation end-products (AGE) can promote chronic kidney disease (CKD) progression and CKD-related morbidities. The soluble receptor for AGE (sRAGE) is a potential biomarker of inflammation and oxidative stress. Here, we explored the role of AGE, glycated albumin, sRAGE and its different for...

Full description

Bibliographic Details
Main Authors:	Elena Dozio, Simone Vettoretti, Lara Caldiroli, Silvia Nerini-Molteni, Lorenza Tacchini, Federico Ambrogi, Piergiorgio Messa, Massimiliano M. Corsi Romanelli
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Biomedicines
Subjects:	advanced glycation end-products (AGE) chronic kidney disease (CKD) mortality soluble receptor for AGE (sRAGE)
Online Access:	https://www.mdpi.com/2227-9059/8/12/638

Similar Items

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021-12-01)

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study
by: Paolo Molinari, et al.
Published: (2023-01-01)

Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2022-06-01)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

The cardiovascular complications of diabetes: a striking link through protein glycation
by: Ahmad Mousa Numan, et al.
Published: (2020-12-01)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
by: Mieke Steenbeke, et al.
Published: (2022-03-01)

P.39 The Role of Advanced Glycation End Products in Vascular Ageing. Which Parameter is the Most Suitable as Biomarker?
by: Otto Mayer, et al.
Published: (2020-12-01)

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
by: Elena Dozio, et al.
Published: (2023-02-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers
by: Elena Dozio, et al.
Published: (2020-11-01)

Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years
by: Julie Magnier, et al.
Published: (2022-06-01)

Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress
by: Elena Dozio, et al.
Published: (2021-04-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a
by: Mahnoosh Rahimi, et al.
Published: (2018-03-01)

Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
by: Stefan Reichert, et al.
Published: (2022-07-01)

Binding of CML-Modified as Well as Heat-Glycated β-lactoglobulin to Receptors for AGEs Is Determined by Charge and Hydrophobicity
by: Hannah E. Zenker, et al.
Published: (2020-06-01)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
by: Sára Csiha, et al.
Published: (2023-05-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Level and Its Prognostic Significance in Children with Acute Lymphoblastic Leukemia
by: Busra Ozkan, et al.
Published: (2024-01-01)

Plasma Levels of Free <i>N</i><i><sup>Ɛ</sup></i>-Carboxymethyllysine (CML) after Different Oral Doses of CML in Rats and after the Intake of Different Breakfasts in Humans: Postprandial Plasma Level of sRAGE in Humans
by: Cynthia Helou, et al.
Published: (2022-04-01)

No Glycation Required: Interference of Casein in AGE Receptor Binding Tests
by: Hannah E. Zenker, et al.
Published: (2021-08-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
by: Aleksandra Twarda-Clapa, et al.
Published: (2022-04-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway
by: Buxing Chen, et al.
Published: (2012-09-01)

Efek Kortikosteroid Dosis Rendah terhadap Kadar Soluble Receptor for Advanced Glycation End Products Mencit Balb/C Model Sepsis
by: Diding Heri Prasetyo, et al.
Published: (2015-03-01)

Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
by: Beatriz Martín-Carro, et al.
Published: (2023-03-01)

The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis
by: Isabella M. Atzeni, et al.
Published: (2023-06-01)

Soluble Receptor for Advanced Glycation End Product Is Involved in the Inflammatory Response of Human Adenovirus-Infected Patients
by: Wen Xu, et al.
Published: (2022-07-01)

Concentrations of N<sup>6</sup>-Carboxymethyllysine (CML), N<sup>6</sup>-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2022-12-01)

Circulating and dietary advanced glycation end products and obesity in an adult population: A paradox of their detrimental effects in obesity
by: Abduladheem Turki Jalil, et al.
Published: (2022-12-01)

The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases
by: Laura M. Senatus, et al.
Published: (2017-12-01)

AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration
by: Reshmee Bhattacharya, et al.
Published: (2023-05-01)

Effect of irisin on metabolic and platelet functions in type 2 diabetic rats: role of soluble receptor of advanced glycation end products (sRAGE)
by: Sherif W. Mansour, et al.
Published: (2021-10-01)

Oleic Acid Status Positively Correlates with the Soluble Receptor for Advanced Glycation End-Products (sRAGE) in Healthy Adults Who Are Homozygous for G Allele of RAGE G82S Polymorphism
by: Permal Deo, et al.
Published: (2023-06-01)

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes
by: Amelia K. Fotheringham, et al.
Published: (2020-09-01)

Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
by: Agnieszka Bronowicka-Szydełko, et al.
Published: (2021-09-01)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
by: Diana Elizabeth González-Guerrero, et al.
Published: (2023-04-01)

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
by: Eva O. Melin, et al.
Published: (2020-10-01)